îæ€çŽ¢
îæ€çŽ¢
î
Synergy CHC Corp
SNYRîãŠã©ãããªã¹ãã«è¿œå
0.028USD
-0.013-31.71%
çµå€Â 09-17 16:00ïŒETïŒ
417.20Kæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
Synergy CHC CorpïŒSNYRïŒç®æšæ ªäŸ¡ïŒèŠéã
ç®æšæ ªäŸ¡
3.750USD+4043.65%
SNYR ã¢ããªã¹ãæšå¥šãã¬ã³ã
ä»æãSNYRã¯0件ã®ãè²·ããã0件ã®ãäžç«ïŒããŒã«ãïŒãã0件ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããSNYRã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯3.750ã§ãã
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
0
1
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
2
2
2
2
2
SNYR åæ¥è æ¯èŒã¢ããªã¹ãè©äŸ¡
æŽæ°æå»: Oct 20, 2026äŒç€Ÿå
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
ã¢ããªã¹ã
Biogen Inc
BIIB
9
17
11
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Regeneron Pharmaceuticals Inc
REGN
7
15
9
0
0
31
財åäºæž¬
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q1ã«çºè¡šãããEPS -0.227ã«ç¶ããSNYRã®FY2026Q2ã®EPSã¯-0.010ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
FY2025Q3
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
äºæž¬å€
0.01
0.01
0.04
-0.01
0.01
å®çžŸå€
0.01
-1.31
-0.23
--
--
ãµãã©ã€ãº
+24.00%
-13237.30%
-749.31%
--
--
ãããã質å
Synergy CHC Corp ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îSynergy CHC Corp ã®äºæ³åç㯠8.30M ã§ãã
Synergy CHC Corp ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãSynergy CHC Corp ã®ç®æšæ ªäŸ¡ã USD 3.75 ãšäºæ³ããæé«äºæ³ã¯ USD 3.75ãæäœäºæ³ã¯ USD 3.75 ãšäºæ³ããŠããŸãã
Synergy CHC CorpSNYR ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.23 ã§ããããSynergy CHC CorpSNYR ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -1.31 ã§ããã次ã®ååæã® EPS 㯠USD -0.01 ãšäºæ³ãããŸãã